Sabinsa Corporation, the vertically integrated, research-oriented company known for sustainable, well-researched nutraceutical and cosmeceutical ingredients, will once again exhibit at Vitafoods Europe, to be held in Geneva, Switzerland from May 9-11, 2023. The company will showcase its innovative range of products and formulations, which includes the first and only EFSA-approved Curcumin product Curcumin C3 Reduct at booth B80.
Sabinsa is proud to announce that Curcumin C3 Reduct is the official curcumin sponsor of the event. This recognition further reinforces the company’s position as a leader in the curcumin market, with a unique product that is backed by years of scientific research.
At the event, Sabinsa will also highlight various product concepts, including, functional drinks, gummies, and other innovative formulations. These products are developed to meet the diverse needs of customers, while ensuring compliance with the regulations of the European Union.
Sabinsa will also highlight products such as Saberry, a unique amla extract which is clinically studied for healthy blood sugar and lipid support; Shagandha, ashwagandha standardized to the USP method; Cirpusins, a clinically studied weight management product; and Nigellin black cumin seed standardized to contain thymoquinone.
Dr. Umar Jan, the President of Sabinsa Europe, said, “At Sabinsa, we remain committed to innovation and our goal is to make Sabinsa Europe and Poland the one-stop destination to supply products, concepts, and formulations that meet the diverse needs of customers.”
With a strong focus on quality and innovation, Sabinsa has established itself as a trusted provider of innovative and effective products to customers worldwide. Sabinsa remains committed to bringing cutting-edge products and solutions to the market.
For more information on Sabinsa’s range of products and formulations, please visit www.sabinsa.eu or visit them at booth B80 at Vitafoods Europe.
About Sabinsa
Sabinsa, founded in 1988, is a manufacturer and supplier of herbal extracts, cosmeceuticals, probiotics, minerals, and specialty fine chemicals. The company markets over 100 standardized botanical extracts and employs more than 1000 people worldwide in 13 manufacturing, R&D, sales, and distribution facilities. Process development and product innovation form the focus of the ongoing R&D efforts in the company’s research facilities, located in India and the U.S. Products, many of which are both Kosher and Halal, are extensively researched, patented, and supported by hundreds of published clinical studies. Sabinsa’s botanical cultivation program totals nearly 20,000 acres to ensure sustainable, fair-trade materials are used in these ingredients. For more information, visit sabinsa.com.